Datos Identificativos | 2014/15 | |||||||||||||
Asignatura | Deseño de novos fármacos específicos (Farmacoloxía e Farmacoxenómica) | Código | 610475504 | |||||||||||
Titulación |
|
|||||||||||||
Descriptores | Ciclo | Período | Curso | Tipo | Créditos | |||||||||
Mestrado Oficial | 2º cuadrimestre |
Primeiro | Optativa | 3 | ||||||||||
|
Bibliografía básica | |
Gielen M., Tiekink R.T , Metallotherapeutic drugs & Metal-based, J.Wiley & Sons, Cornwall 2005, Sessler, J.L., Doctrow, S.R, McMurry, T.J.,Lippard, S.J. , MedicinalInorganic Chemistry, ACS, Washington, 2005, Lukehart M., Scott, R.A. , Nanomaterials: Inorganicand Bioinorganic, John Wiley & Sons, Chichester, 2008 E. I. Pertsov , Nanomaterials: New ResearchDevelopments, Nova. New York. 2008. Martin M. Zdanowicz, Concepts inPharmacogenomics , ASHP; 1 edition (January 1, 2010) , Federico Innocenti , Genomics and Pharmacogenomicsin Anticancer Drug Development and Clinical Response (Cancer Drug Discovery andDevelopment) , Humana Press; 1 edition (October 23, 2008) , Bernd Meibohm , Pharmacokinetics andPharmacodynamics of Biotech Drugs: Principles and Case Studies in DrugDevelopment , Wiley-VCH; 1 edition (January 2, 2007) |
|
Bibliografía complementaria | |
|